Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo
2023-01-05 09:00
OnCusp Therapeutics Announces Appointment of Robert Forrester and Chau Khuong to Board of Directors
2023-01-04 21:00
Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program
2023-01-04 21:00
Alterity Therapeutics to Participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum
2023-01-03 23:25
Bridge Biotherapeutics to Present at BIOTECH SHOWCASE™ 2023
2023-01-03 22:00
WeTrade Group Wins the "Strongest Potential IPO" Award While Launching the 2023 Multi-Industry Diversification Strategy
2023-01-03 22:02
ProfoundBio Announces Initiation of First-in-Human Trial for PRO1184, a Folate Receptor Alpha-Directed ADC with a Topoisomerase 1 Inhibitor Payload, and Receives FDA "Study May Proceed" Letter for PRO1160, a CD70-Directed ADC
2023-01-03 20:00
Everest Medicines Announces New Strategic Plans, Reinforcing Transformation into a Fully Integrated Biopharmaceutical Company
2023-01-03 16:00
Bayer Taiwan Company Ltd. and Berocca Honored at the Asia Pacific Enterprise Awards 2022 Taiwan
2023-01-03 10:05
Ascletis Believes that the Complaints Made by Viking Therapeutics Have No Merit and will Vigorously Defend Against such Complaints
2023-01-02 19:24
Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates
2022-12-30 21:00
Fosun International Garners Multiple ESG Awards in Domestic and International Markets
2022-12-30 10:21
Complete Genomics to Present its Multiple, Innovative Sequencing Platforms at BIOTECH SHOWCASE™ 2023
2022-12-30 01:58
Alterity Therapeutics Announces Allowance of New Composition of Matter Patent by the United States Patent and Trademark Office
2022-12-29 23:25
Duoning maintains supply chain stability with operation of factory in Wuxi
2022-12-29 20:00
China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask
2022-12-28 21:00
Takeda Healthcare Philippines Inc Honored the Inspirational Award at the Asia Pacific Enterprise Awards 2022 Regional Edition
2022-12-28 15:30
Non-invasive in vitro diagnostic (IVD) test enables early detection of colorectal cancer
2022-12-27 23:59
Brii Biosciences Provides Update on Strategic Clinical Development Progress
2022-12-27 20:00
GeneQuantum and WuXi XDC Entered into Strategic Collaboration to Empower Innovative Bioconjugate Development
2022-12-26 23:01
1
59
60
61
62
63
150